Literature DB >> 31251394

Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape.

Samilia Obeng-Gyasi1, Sheetal M Kircher2, Kelsey P Lipking1, Benjamin J Keele3, Al B Benson2, Lynne I Wagner4, Ruth C Carlos5.   

Abstract

Entities:  

Keywords:  Affordable Care Act; Medicaid; Medicare; clinical trials; insurance; oncology

Mesh：

Year:  2019        PMID： 31251394      PMCID： PMC6763351          DOI： 10.1002/cncr.32360

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  43 in total

1.  Cost of care for patients in cancer clinical trials.

Authors:  B H Fireman; L Fehrenbacher; E P Gruskin; G T Ray
Journal:  J Natl Cancer Inst       Date:  2000-01-19       Impact factor: 13.506

2.  Medicare to cover routine care costs in clinical trials.

Authors:  K Arnold; B Vastag
Journal:  J Natl Cancer Inst       Date:  2000-07-05       Impact factor: 13.506

3.  Enrollment of older persons in cancer trials after the medicare reimbursement policy change.

Authors:  Cary P Gross; Natalie Wong; Joel A Dubin; Susan T Mayne; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2005-07-11

4.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Authors:  P N Lara; R Higdon; N Lim; K Kwan; M Tanaka; D H Lau; T Wun; J Welborn; F J Meyers; S Christensen; R O'Donnell; C Richman; S A Scudder; J Tuscano; D R Gandara; K S Lam
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  Disparities in cancer diagnosis and survival.

Authors:  C J Bradley; C W Given; C Roberts
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

6.  Incremental costs of enrolling cancer patients in clinical trials: a population-based study.

Authors:  J L Wagner; S R Alberts; J A Sloan; S Cha; J Killian; M J O'Connell; P Van Grevenhof; J Lindman; C G Chute
Journal:  J Natl Cancer Inst       Date:  1999-05-19       Impact factor: 13.506

7.  An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.

Authors:  Cynthia L Martel; Yueju Li; Laurel Beckett; Helen Chew; Scott Christensen; Angela Davies; Kit S Lam; Derick H Lau; Frederick J Meyers; Robert T O'donnell; Carol Richman; Sidney Scudder; Michael Tanaka; Joseph Tuscano; Jeanna Welborn; Theodore Wun; David R Gandara; Primo N Lara
Journal:  Cancer J       Date:  2004 Sep-Oct       Impact factor: 3.360

8.  Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.

Authors:  Michael S Simon; Wei Du; Lawrence Flaherty; Philip A Philip; Patricia Lorusso; Cheryl Miree; Daryn Smith; Diane R Brown
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

9.  Cancer trial enrollment after state-mandated reimbursement.

Authors:  C P Gross; V Murthy; Y Li; A D Kaluzny; H M Krumholz
Journal:  J Natl Cancer Inst       Date:  2004-07-21       Impact factor: 13.506

10.  Incremental treatment costs in national cancer institute-sponsored clinical trials.

Authors:  Dana P Goldman; Sandra H Berry; Mary S McCabe; Meredith L Kilgore; Arnold L Potosky; Michael L Schoenbaum; Matthias Schonlau; Jane C Weeks; Richard Kaplan; Jose J Escarce
Journal:  JAMA       Date:  2003-06-11       Impact factor: 56.272
View more
  3 in total

1.  Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.

Authors:  Cristina Merkhofer; Shasank Chennupati; Qin Sun; Keith D Eaton; Renato G Martins; Scott D Ramsey; Bernardo H L Goulart
Journal:  JCO Oncol Pract       Date:  2021-08

2.  Clinical trial agreements and insurance policies - role of the EC.

Authors:  Ravindra Bhaskar Ghooi
Journal:  Perspect Clin Res       Date:  2022-06-30

3.  Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.

Authors:  Gelareh Sadigh; Robert J Gray; Joseph A Sparano; Betina Yanez; Sofia F Garcia; Lava R Timsina; George W Sledge; David Cella; Lynne I Wagner; Ruth C Carlos
Journal:  Cancer       Date:  2021-04-01       Impact factor: 6.921
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.